Answers are grounded in this paper and cite their sources.
Systematic review and meta-analysis shows promising survival alongside high graft rejection and renal complication rates in failing Fontan patients, indicating a need for refined management protocols.
CHLT in Fontan patients demonstrates promising survival rates, but graft rejection and postoperative complications pose challenges. The rate of renal complications is particularly notable and requires further evaluation. Future research should prioritize comparative different management strategies and long-term follow-up to refine protocols and optimize outcomes.
No takes yet. Share an insight, caveat, or question.
Vizentin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: